PRME position history
The shares of Prime Medicine (PRME) that ARK Investment Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2022 Q4: 1,639,984 shares, $30M, 0.26% of portfolio, New
- 2023 Q1: 1,922,277 shares, $24M, 0.16% of portfolio, Add +17.2%
- 2023 Q2: 2,449,199 shares, $36M, 0.24% of portfolio, Add +27.4%
- 2023 Q3: 2,622,429 shares, $25M, 0.19% of portfolio, Add +7.1%
- 2023 Q4: 3,138,270 shares, $28M, 0.16% of portfolio, Add +19.7%
- 2024 Q1: 5,993,354 shares, $42M, 0.29% of portfolio, Add +91.0%
- 2024 Q2: 6,126,773 shares, $31M, 0.28% of portfolio, Add +2.2%
- 2024 Q3: 5,660,719 shares, $22M, 0.20% of portfolio, Reduce −7.6%
- 2024 Q4: 5,150,233 shares, $15M, 0.13% of portfolio, Reduce −9.0%
- 2025 Q1: 3,095,172 shares, $6.2M, 0.06% of portfolio, Reduce −39.9%
- 2025 Q2: 2,322,669 shares, $5.7M, 0.04% of portfolio, Reduce −25.0%
- 2025 Q3: 5,477,851 shares, $30M, 0.18% of portfolio, Add +135.8%
- 2025 Q4: 5,368,526 shares, $19M, 0.12% of portfolio, Reduce −2.0%
- 2026 Q1: 6,246,827 shares, $22M, 0.17% of portfolio, Add +16.4%
- 2026 Q2: 8,348,746 shares, $31M, 0.20% of portfolio, Add +33.6%
- 2026 Q3: 10,043,509 shares, $31M, 0.18% of portfolio, Add +20.3%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|